Inactivated dengue virus vaccine with aluminium-free adjuvant

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9265821
APP PUB NO 20110318407A1
SERIAL NO

13148741

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure provides immunogenic compositions for the prevention and/or treatment of disease caused by dengue virus.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • GLAXOSMITHKLINE BIOLOGICALS SA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baras, Benoit Rixensart, BE 4 10
Gheysen, Dirk Rixensart, BE 6 37
Knott, Isabelle Solange Lucie Rixensart, BE 5 35
Prieels, Jean-Paul Rixensart, BE 21 209
Toussaint, Jean-Francois Rixensart, BE 6 9

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 23, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00